Search

everythinglearnresearchcommunity

for

Search:↓

RC48 shows promise for treating certain advanced cancers, but more research is needed.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

Cats likely have a reactive skin condition, while dogs may have a more complex, possibly cancerous one.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.

Deleting the CD271 gene in mouse skin cells leads to disorganized skin and increased hair growth, suggesting CD271 is important for skin health.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Using DNase enzymes to break down harmful NETs could be a new treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Different γδ T cell types have unique roles in causing alopecia areata.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

MK-5108 is safe and shows potential against tumors, especially alone.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.